Buscar
Mostrando ítems 1-10 de 215
Abordagem terapêutica da Leishmaniose Visceral no Brasil: revisão para clínicosTherapeutic approach of Visceral Leishmaniasis in Brazi: a review for the clinicians
(Universidade Católica de Brasília, 2020)
Preclinical Studies Evaluating Subacute Toxicity and Therapeutic Efficacy of LQB-118 in Experimental Visceral Leishmaniasis
(American Society for Microbiology, 2017)
Occurrence of two autochthonous cases of American cutaneous leishmaniasis in the neighborhood of Caju, city of Rio de Janeiro, Brazil
(Sociedade Brasileira de Dermatologia, 2015)
Ursolic acid potentializes conventional therapy in experimental leishmaniasis
(2020-10-01)
Ursolic acid (UA) is a triterpene with a broad array of pharmacological activities. In leishmaniasis, UA killed different species of parasites, and it was active in the experimental model of cutaneous and visceral ...
Cost-effectiveness analysis of diagnostic-therapeutic strategies for visceral leishmaniasis in Brazil
(Sociedade Brasileira de Medicina Tropical, 2019)
Two cases of visceral leishmaniasis in Colombia resistant to meglumine antimonial treatment
(Universidade de São Paulo, Instituto de Medicina Tropical de São PauloPrograma de Estudio y Control de Enfermedades Tropicales (PECET)São Paulo, Brasil, 2022)
Predictors of relapse of visceral leishmaniasis in inner São Paulo State, Brazil
(2020-06-01)
Objectives: Visceral leishmaniasis (VL) is a public health threat for several tropical countries, including Brazil. Therapy failures and relapses aggravate VL morbidity and mortality. Our study aimed at identifying predictors ...
The direct costs of treating human visceral leishmaniasis in Brazil
(Sociedade Brasileira de Medicina Tropical, 2018)
Canine visceral leishmaniasis in Rio de Janeiro, Brazil. Clinical, parasitological, therapeutic and empidemiological findings (1977-1983)
(Fundação Oswaldo Cruz. Instituto Oswaldo Cruz., 2020)